EMP2 and endometrial cancer: Conversely, EMP2 was identified as an early predictor of endometrial cancers with unfavorable outcome by activation of protein tyrosine kinase 2 (PTK2 or FAK) and v-src avian sarcoma viral oncogene homolog (SRC) [26, 27].